Search Results for citation:"90 FR 1175"

The National Institute of Allergy and Infectious Diseases has announced a closed meeting scheduled for January 24, 2025, from 1:00 p.m. to 4:00 p.m. The meeting is closed to the public due to confidential discussions about contract proposals, which may include sensitive commercial information or personal data. This meeting involves the review and evaluation of proposals related to devices and materials-based platforms for delivering broadly neutralizing antibodies. The session will be held in Rockville, MD, but will be video-assisted, and Dr. Samita S. Andreansky will serve as the contact person for the meeting.

The National Institutes of Health (NIH) is holding a closed meeting organized by the National Institute of Allergy and Infectious Diseases from January 30 to 31, 2025, to discuss contract proposals. The meeting, which will take place at the NIH's location in Rockville, Maryland, will not be open to the public because it may involve sensitive information, such as trade secrets or personal details that must remain confidential. The purpose of the meeting is to evaluate proposals for the Small Business Innovation Research (SBIR) program, with a focus on adjuvant development for vaccines.